BioSensics to Validate Digital Health Tech for PSP and DLB Monitoring
BioSensics is leading a study to validate wearable digital health technologies for monitoring motor function in PSP, MCI-LB, and DLB.
Asset / Drug
Drug and asset intelligence for PSP with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.